相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings
Palwasha Y. Khan et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country
Dumitru Chesov et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study
Li Shi et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States
Sundari Mase et al.
CLINICAL INFECTIOUS DISEASES (2020)
A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis
Olatunde Olayanju et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
Abela Mpobela Agnarson et al.
BMC INFECTIOUS DISEASES (2020)
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
Giovanni Battista Migliori et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study
Ying Zhao et al.
CLINICAL INFECTIOUS DISEASES (2019)
Outcomes of Bedaquiline Treatment in Patients with Multidrug Resistant Tuberculosis
Lawrence Mbuagbaw et al.
EMERGING INFECTIOUS DISEASES (2019)
Clofazimine: A useful antibiotic for drug-resistant tuberculosis
Reza Mirnejad et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study
Lorenzo Guglielmetti et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
Olatunde Olayanju et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
Kathryn Schnippel et al.
LANCET RESPIRATORY MEDICINE (2018)
Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study
Nazir A. Ismail et al.
EBIOMEDICINE (2018)
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad et al.
LANCET (2018)
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
Norbert Ndjeka et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis
Jian Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Alexander S. Pym et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan
Irfan Ullah et al.
PLOS ONE (2016)
WHO's new End TB Strategy
Mukund Uplekar et al.
LANCET (2015)
Linezolid in the treatment of extensively drug-resistant tuberculosis
L. Zhang et al.
INFECTION (2014)
Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
Kathy Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Myungsun Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Global Burden of Tuberculosis - Combating Drug Resistance in Difficult Times
Peter R. Donald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
分享论文
